BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 24992071)

  • 21. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP; Mezina A; Shaib WL; Landry J; El-Rayes BF
    Eur J Cancer; 2016 Jan; 52():109-19. PubMed ID: 26682870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor-mediated down-regulation of neutral endopeptidase (NEP; EC 3.4.24.11; CD10) on immature B lymphocytes by dexamethasone.
    Cupic B; Breljak D; Gabrilovac J
    Int J Mol Med; 2005 Jun; 15(6):1023-31. PubMed ID: 15870909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cationic lipid-conjugated hydrocortisone as selective antitumor agent.
    Rathore B; Chandra Sekhar Jaggarapu MM; Ganguly A; Reddy Rachamalla HK; Banerjee R
    Eur J Med Chem; 2016 Jan; 108():309-321. PubMed ID: 26695732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
    Runnebaum IB; Brüning A
    Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa.
    Lu YS; Yeh PY; Chuang SE; Gao M; Kuo ML; Cheng AL
    J Endocrinol; 2006 Feb; 188(2):311-9. PubMed ID: 16461557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
    Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
    Tong Q; Qing Y; Wu Y; Hu X; Jiang L; Wu X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):166-73. PubMed ID: 25111127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas.
    Herr I; Ucur E; Herzer K; Okouoyo S; Ridder R; Krammer PH; von Knebel Doeberitz M; Debatin KM
    Cancer Res; 2003 Jun; 63(12):3112-20. PubMed ID: 12810637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone Downregulates SLC7A5 Expression and Promotes Cell Cycle Arrest, Autophagy and Apoptosis in BeWo Cells.
    He B; Zhang N; Zhao R
    J Cell Physiol; 2016 Jan; 231(1):233-42. PubMed ID: 26094588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
    Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.
    Agarwalla P; Mukherjee S; Sreedhar B; Banerjee R
    Nanomedicine (Lond); 2016 Oct; 11(19):2529-46. PubMed ID: 27622735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts.
    Zhen YF; Wang GD; Zhu LQ; Tan SP; Zhang FY; Zhou XZ; Wang XD
    J Cell Physiol; 2014 Oct; 229(10):1475-83. PubMed ID: 24615518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor activity of lysophosphatidic acid acyltransferase-beta inhibitors, a novel class of agents, in multiple myeloma.
    Hideshima T; Chauhan D; Hayashi T; Podar K; Akiyama M; Mitsiades C; MItsiades N; Gong B; Bonham L; de Vries P; Munshi N; Richardson PG; Singer JW; Anderson KC
    Cancer Res; 2003 Dec; 63(23):8428-36. PubMed ID: 14679006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
    Moon DO; Lee KJ; Choi YH; Kim GY
    Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids augment survival and proliferation of tumor cells.
    Gündisch S; Boeckeler E; Behrends U; Amtmann E; Ehrhardt H; Jeremias I
    Anticancer Res; 2012 Oct; 32(10):4251-61. PubMed ID: 23060545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
    Feldkamp MM; Lau N; Guha A
    Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The glucocorticoid receptor is increased in Atm-/- thymocytes and in Atm-/- thymic lymphoma cells, and its nuclear translocation counteracts c-myc expression.
    Yan M; Kuang X; Scofield VL; Shen J; Lynn WS; Wong PK
    Steroids; 2007 May; 72(5):415-21. PubMed ID: 17418878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
    Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.